NDRG2 has been reported to be reduced within colorectal cancer, liver cancer, thyroid cancer, glioblastoma, breast cancer and a number of other human cancers [16, 17, 20, 23, 32, 33]. This evidence concerns the gene NDRG2 and thyroid cancer.